Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCC
NCT02563158 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114
Last updated 2016-05-12
Summary
The study aims to compare the perioperative and long-term outcomes of liver resection for HBV-related HCC with versus without hepatic inflow occlusion.
Conditions
- Liver Cancer
- Surgery
Interventions
- PROCEDURE
-
non-occlusion technique
Hepatectomy is carried out without hepatic inflow control. (non-occlusion technique)
Sponsors & Collaborators
-
Chinese PLA General Hospital
lead OTHER
Principal Investigators
-
Shichun Lu, MD, PhD · Department of Hepatobiliary Surgery, Chinese PLA General Hospital, 28 Fuxing Road, Haidian, Beijing, 100853, China
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2019-01-31
- Completion
- 2019-01-31
Countries
- China
Study Locations
More Related Trials
-
Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels
NCT00814242 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients
NCT02523053 ·Status: UNKNOWN ·Phase: NA
-
Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma
NCT01415063 ·Status: UNKNOWN ·Phase: PHASE4
-
Non-inferiority Study of Unresectable Hepatocelluar Carcinoma Receiving Stereotactic Radiotherapy Combined With Hepatic Arterial Chemoembolization Compared With Conversion Hepatectomy
NCT05057104 ·Status: UNKNOWN
-
TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma
NCT01833286 ·Status: UNKNOWN ·Phase: PHASE3
-
Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma
NCT06405321 ·Status: RECRUITING
-
Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma
NCT06365034 ·Status: RECRUITING
-
Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.
NCT03790059 ·Status: UNKNOWN ·Phase: NA
-
Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular Carcinoma
NCT00652587 ·Status: COMPLETED ·Phase: PHASE3
-
Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular Carcinoma
NCT01088581 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm
NCT00479050 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy
NCT01828762 ·Status: COMPLETED ·Phase: NA
-
Observational Study on Patients With Hepatocellular Carcinoma (HCC)
NCT04021056 ·Status: UNKNOWN
-
Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot Study
NCT06685354 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
International Study on Treatment of Liver (HCC) Patients With IRE
NCT07192731 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Radiofrequency-assisted Liver Resection in Intractable Liver Cancer
NCT04413526 ·Status: COMPLETED
-
Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence
NCT00817895 ·Status: COMPLETED ·Phase: NA
-
Primary Hepatobiliary Cancer Cohort of Central China
NCT05520801 ·Status: RECRUITING
-
Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma
NCT07077356 ·Status: RECRUITING ·Phase: PHASE1
-
Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma
NCT03662841 ·Status: TERMINATED ·Phase: NA
-
The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma
NCT00720668 ·Status: UNKNOWN
-
En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant Criteria
NCT06850753 ·Status: RECRUITING ·Phase: NA
-
Antiviral Therapy for Patients With Liver Cancer After Surgery
NCT05466565 ·Status: RECRUITING
-
Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus
NCT01600196 ·Status: TERMINATED ·Phase: PHASE4
-
HR Combined With FOLFOX4 for HCC With PVTT
NCT02452853 ·Status: UNKNOWN ·Phase: PHASE2